Go to the list of all blogs
published in Blogs
Aug 10, 2026
DigitalOcean (DOCN) Pulls Back About 5% After Strong Q2 AI Inference Growth

DigitalOcean (DOCN) Pulls Back About 5% After Strong Q2 AI Inference Growth

Key Takeaways

  • DigitalOcean shares have pulled back roughly 5% over the past 30 days, trading near $124 after a volatile quarter that saw the stock swing from above $180 in early June to current levels.
  • Second-quarter 2026 results exceeded consensus estimates on both revenue ($281.2 million, up 28.6% year-over-year) and non-GAAP EPS ($0.45 vs. $0.26 expected), yet the stock dropped sharply immediately following the report.
  • AI Customer ARR surged 212% year-over-year to $234 million, now representing 21% of total company ARR, driven by the Inference Engine launched in late April and accelerating demand for inference workloads.
  • Management raised full-year 2026 revenue guidance to $1.17–$1.18 billion, implying approximately 30.5% growth, and signaled confidence in 50%+ growth exiting into 2027.
  • Margin compression, a GAAP net income decline, and a completed $472 million convertible note repurchase added complexity to an otherwise strong operational quarter.

Current Market Snapshot

DigitalOcean Holdings, Inc. (DOCN) has experienced notable turbulence in recent months. After rallying from roughly $100 in early May 2026 to an intra-quarter peak above $180 in early June, the stock has retraced meaningfully and now trades near $124. The 30-day decline of approximately 4.9% masks deeper intraday volatility, including a sharp 10.9% drop the day after Q2 earnings were released. Broader cloud computing and AI infrastructure stocks have faced heightened scrutiny as investors weigh accelerated revenue growth against rising capital expenditures and margin pressure, and DOCN sits squarely within that debate. To get a quick sense of how it stacks up against peers, I also checked this using Tickeron’s AI Screener.

DigitalOcean’s AI-Native Cloud Positioning

DigitalOcean positions itself as the AI-Native Cloud, purpose-built for inference and agentic workloads. Its five-layer integrated platform spans GPU and CPU infrastructure, core cloud services, inference, data management, and managed agent orchestration — all designed to be open and free from vendor lock-in. With more than 650,000 customers and millions of developers globally, DigitalOcean caters to startups, digital-native enterprises, and AI-focused companies seeking simplified cloud solutions at competitive price points. The company competes with hyperscalers like AMZN (AWS), MSFT (Azure), and GOOGL (Google Cloud), differentiating through developer-centric tools, transparent pricing, and a growing focus on inference — the process of running live AI models — rather than just training infrastructure.

Q2 2026 Results and Market Reaction

The most consequential event in the last 30 days was DigitalOcean’s Q2 2026 earnings release on August 4. Revenue climbed 28.6% year-over-year to $281.2 million, beating consensus estimates of approximately $278 million. Non-GAAP EPS of $0.45 crushed the $0.26 analyst forecast. Record incremental ARR of $93 million — nearly triple the prior-year figure — underscored the acceleration in customer spending. AI Customer ARR reached $234 million, with inference services growing nearly 800% year-over-year and accounting for over 70% of total AI customer ARR.

Despite these headline beats, the stock sold off. Investors focused on GAAP net income declining to $35.4 million from $37.0 million a year earlier, gross margin contracting 490 basis points to 55%, and rising R&D expenses that surged 45% year-over-year. The market also digested the completion of a $472 million repurchase of 2030 convertible notes in late July, which was structured as a registered direct offering of approximately 12.5 million shares at $117.54 per share. While management emphasized zero net dilution, the transaction introduced near-term supply pressure and complexity into the equity story.

On the product front, the Inference Engine launched in late April surpassed 6,000 customers by quarter-end, with token volume increasing 30-fold over 60 days. Open-weight model usage expanded from roughly 15% to nearly 75% of token traffic, signaling a rapid shift toward cost-efficient inference. The company also secured an additional 20 megawatts of data center capacity, bringing total committed capacity to approximately 155 MW.

2026 Outlook and Key Factors to Monitor

DigitalOcean enters the second half of 2026 with significant momentum in its AI business but faces several crosscurrents. Management raised full-year revenue guidance to $1.17–$1.18 billion and projected Q4 exit growth of at least 35%, with preliminary confidence in 50%+ growth for 2027. The $894 million in remaining performance obligations — more than 12 times the prior-year level with a 3.7-year average duration — provides multi-year revenue visibility.

Key factors to monitor include the pace of Inference Engine adoption, margin trajectory as GPU-related infrastructure investments scale, and the timely delivery of committed data center capacity. Competitive pressure from hyperscalers and specialized AI cloud providers remains a structural risk. Additionally, concentration risk is rising: the top 25 customers now represent approximately 20% of ARR. The company’s ability to translate AI demand into sustained GAAP profitability and free cash flow generation will likely determine whether the recent pullback represents a buying opportunity or a justified re-rating. I’m watching this closely as the AI segment scales.

AI Trading Bots for Market Analysis

As part of my regular research routine, I often review Tickeron’s Trending AI Robots page for perspectives on volatile names like DOCN. The platform highlights top-performing AI-powered trading bots across strategies and timeframes, offering a streamlined way to explore signals that may align with shifting market conditions.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: DOCN

DOCN's RSI Oscillator ascending out of oversold territory

The RSI Oscillator for DOCN moved out of oversold territory on July 17, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 24 similar instances when the indicator left oversold territory. In of the 24 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 58 cases where DOCN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 07, 2026. You may want to consider a long position or call options on DOCN as a result. In of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for DOCN just turned positive on August 03, 2026. Looking at past instances where DOCN's MACD turned positive, the stock continued to rise in of 54 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DOCN advanced for three days, in of 308 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

DOCN moved below its 50-day moving average on July 01, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for DOCN crossed bearishly below the 50-day moving average on July 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DOCN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for DOCN entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DOCN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (15.674) is normal, around the industry mean (24.189). P/E Ratio (56.432) is within average values for comparable stocks, (72.005). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.893). DOCN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.021). P/S Ratio (13.986) is also within normal values, averaging (131.586).

Notable companies

The most notable companies in this group are Microsoft Corp (NASDAQ:MSFT), Oracle Corp (NYSE:ORCL), Palo Alto Networks Inc (NASDAQ:PANW), Crowdstrike Holdings Inc (NASDAQ:CRWD), Block Inc (NYSE:XYZ), NetApp (NASDAQ:NTAP), Twilio (NYSE:TWLO), MongoDB (NASDAQ:MDB), Zscaler (NASDAQ:ZS), Okta (NASDAQ:OKTA).

Industry description

Computer communications industry develops technology that allows computing devices to exchange data with each other using connections/data links between nodes. Common types of computer network include Cloud (IAN), Internet, Wide (WAN, Local (LAN)/Wireless(WLAN) etc. The industry is an ever-more important part of technology, and is set to become even bigger as the Internet of Things (IoT) rapidly forays into the various aspects of our lives. Cisco Systems, Inc., Palo Alto Networks, Inc. and Arista Networks, Inc., Fortinet, Inc. are some of the major computer communications companies.

Market Cap

The average market capitalization across the Computer Communications Industry is 34.85B. The market cap for tickers in the group ranges from 48.8K to 3.71T. MSFT holds the highest valuation in this group at 3.71T. The lowest valued company is WMHI at 48.8K.

High and low price notable news

The average weekly price growth across all stocks in the Computer Communications Industry was 3%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was 24%. AEVA experienced the highest price growth at 52%, while WETO experienced the biggest fall at -99%.

Volume

The average weekly volume growth across all stocks in the Computer Communications Industry was 10%. For the same stocks of the Industry, the average monthly volume growth was 6% and the average quarterly volume growth was -45%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 73
Price Growth Rating: 56
SMR Rating: 80
Profit Risk Rating: 91
Seasonality Score: -6 (-100 ... +100)
View a ticker or compare two or three
DOCN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry ComputerCommunications

Profile
Details
Industry
N/A
Address
101 6th Avenue
Phone
+1 646 827-4366
Employees
1156
Web
https://www.digitalocean.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
DigitalOcean (DOCN) Pulls Back About 5% After Strong Q2 AI Inference Growth